Access this stock data via API
Subscribe
Sinopharm Group Co., Ltd.
0
0
0%

Financials

Income statement

Fundamentals currency is CNY
Fiscal date 2024 2023 2022 2021
Total reported revenue 645.2B 650.3B 552.1B 521.1B
Cost of revenue 596.3B 597.4B 504.7B 477.0B
Gross profit 48.8B 52.9B 47.4B 44.1B
Operating expense
Research & development
Selling general and admin 28.2B 28.5B 24.9B 23.2B
Other operating expenses 1.5B 727.1M 666.5M
Operating income 19.6B 24.3B 22.5B 21.4B
Non operating interest income
Income 681.0M 810.3M 542.8M 558.6M
Expense 3.0B 3.2B 3.5B 3.8B
Other income expense
Pretax income 15.5B 21.3B 18.6B 17.0B
Tax provision 3.9B 4.9B 4.2B 3.9B
Net income 11.5B 16.4B 14.3B 13.1B
Basic EPS 2.3 2.9 2.7 2.5
Diluted EPS 2.3 2.9 2.7 2.5
Basic average shares 3.4B 3.4B 2.9B 2.9B
Diluted average shares 3.4B 3.4B 2.9B 2.9B
EBITDA 26.6B 31.0B 28.1B 26.8B
Net income from continuing op. 15.5B 21.3B 18.6B 17.0B
Minority interests -3.4B -6.0B -5.8B -5.3B
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 4 hours 30 minutes

11:29
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
09:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 16:10
All times are displayed in the Asia/Hong_Kong timezone (HKT, UTC+08:00).